These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?]. Klose G MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683 [No Abstract] [Full Text] [Related]
5. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612 [TBL] [Abstract][Full Text] [Related]
6. Do people with diabetes need statins? White JR Diabetes Educ; 2008; 34(4):664-73. PubMed ID: 18669808 [TBL] [Abstract][Full Text] [Related]
7. How to balance cardiometabolic benefits and risks of statins. Koh KK J Am Coll Cardiol; 2013 May; 61(18):1932-3. PubMed ID: 23500235 [No Abstract] [Full Text] [Related]
8. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study). Betteridge DJ; Gibson JM; Sager PT Am J Cardiol; 2007 Oct; 100(8):1245-8. PubMed ID: 17920365 [TBL] [Abstract][Full Text] [Related]
11. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. Faergeman O; Hill L; Windler E; Wiklund O; Asmar R; Duffield E; Sosef F; Cardiology; 2008; 111(4):219-28. PubMed ID: 18434729 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients. Sharma R; Mahajan M; Singh B; Bal BS; Kant R J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006 [TBL] [Abstract][Full Text] [Related]
14. How to reach LDL targets quickly in patients with diabetes or metabolic syndrome. Leiter LA; Martineau P; de Teresa E; Farsang C; Gaw A; Gensini G; Langer A; J Fam Pract; 2008 Oct; 57(10):661-8. PubMed ID: 18842192 [TBL] [Abstract][Full Text] [Related]
15. Higher dose of statin medication may be better for older adults. Mayo Clin Womens Healthsource; 2007 Dec; 11(12):3. PubMed ID: 17993998 [No Abstract] [Full Text] [Related]
16. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. Athyros VG; Tziomalos K; Kakafika AI; Koumaras H; Karagiannis A; Mikhailidis DP Am J Cardiol; 2008 Feb; 101(4):483-5. PubMed ID: 18312762 [TBL] [Abstract][Full Text] [Related]
18. ACP Journal Club. Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease. Sethi SS; Farkouh ME Ann Intern Med; 2013 Jul; 159(2):JC3. PubMed ID: 23856701 [No Abstract] [Full Text] [Related]
19. Statins and CVD prevention in the diabetic population: implications of the CARDS trial. Murad O; Palmer J; Sowers J; McFarlane SI Curr Diab Rep; 2005 Jun; 5(3):191-3. PubMed ID: 15929865 [No Abstract] [Full Text] [Related]
20. Should you put all diabetic patients on statins? Leiter LA J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328 [No Abstract] [Full Text] [Related] [Next] [New Search]